A typology-based decisional framework to support market access and reimbursement decisions for personalised medicines
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Publication type
Journal articlePublication Year
2017Journal
Value in Health. The Journal of the International Society for Pharmacoeconomics and Outcomes ResearchPublication Volume
20Publication Issue
9Publication Begin page
A661Publication End page
A661
Metadata
Show full item recordAbstract
New co-development approaches in personalized medicine challenge current decisional frameworks of health-technology access and reimbursement procedures. We aim to conceptualize an efficient typology-based decisional framework which takes into account the development and market access synchronism between therapeutic (Tx) and diagnostic (Dx) components of personalized medicines.Knowledge Domain/Industry
Special Industries : Healthcare Managementae974a485f413a2113503eed53cd6c53
10.1016/j.jval.2017.08.1586